Skip to main content
Premium Trial:

Request an Annual Quote

Amelia Warner

Predictive Oncology has appointed Amelia Warner as the interim chief operating officer of its Helomics subsidiary. Prior to joining Helomics, Warner founded Global Specimens Solutions in 2013. Before GSS, Warner served as CEO for Gentris. She has also served as head of clinical pharmacogenomics and clinical specimen management for Merck. In addition, she has served as chair of the Industry Pharmacogenomics Working Group. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.